NCT06445062 2026-03-13Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsRevolution Medicines, Inc.Phase 1/2 Recruiting1,130 enrolled
NCT06447662 2026-02-25A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.PfizerPhase 1 Recruiting330 enrolled
NCT07259317 2026-02-20Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaCorcept TherapeuticsPhase 2 Recruiting60 enrolled
NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled
NCT05288205 2025-04-04Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C MutationAllist Pharmaceuticals, Inc.Phase 1/2 Recruiting240 enrolled